South Africa
February 5, 2007
Presentation
by Mr Lourie Bosman, President of Agri SA., Tuesday, 23 January
2007 in Pretoria, South Africa
The production of
GM crops in South Africa – maize, soya and cotton – in 2006
totalled an impressive 1.4 million ha. This is a significant
increase of 180% over the previous year’s 500 000 ha. White and
yellow maize topped the list with more than one million hectares
followed by soya and cotton.
This is the
second highest percentage increase of any country in the world
surpassed only by India with 192% increase.
South Africa is
also a major producer of GM maize seed produced by numerous
commercial and emergent farmers. In 2006 some 1232 metric tons
worth R37 million were exported earning South Africa valuable
foreign exchange.
South Africa is
also a regular exporter of GM and non-GM cotton seed.
These
achievements, in no uncertain terms, reflect the trust and
confidence of thousands of South African commercial and emergent
farmers and consumers in crop biotechnology as the leaders in
Africa of this unique agricultural technology, says Mr Lourie
Bosman, president Agri SA.
Speaking at a
press conference in Pretoria, he said according to the latest
figures released by Clive James, chairman of ISAAA (International
Service for the Acquisition of Agri-Biotech Applications),
the global adoption of biotech crops in 2006 was the fastest
crop technology advance in recent history.
In 2006 10.3
million farmers (8.5 m 2005) in 22 countries (21) planted 102
million hectares (90 m) of GM crops. This is an increase of 12
million ha or 13% over the previous year. This is the tenth
consecutive year that biotech crops continued to climb at a
sustained double-digit growth rate.
“This is an
historical landmark in that it is the first time that more than
100 million hectares of biotech crops were grown in any one
year,” said Bosman.
Of the 10.3
million farmers 9.3 million (7.7 m) were small, resource poor
farmers from developing countries whose increased income from
biotech crops contributed to their poverty alleviation.
Most of them were
Bt cotton farmers – China 6.8 million, India 2.3 million,
Philippines
100 000, and in
South Africa several thousand. Of the 22 countries 11 are
developing countries. The biggest growth was in India who for
the first time grew 3.8 million ha Bt cotton, up from 1.3
million ha the previous year, exceeding China’s 3.5 million ha.
In South Africa
more than 2000 emergent farmers planted biotech crops.
Biotech crops in
developing countries have increased consistently every year
during the past ten years with an increase of seven million ha
in 2006 over the previous year, totalling 40.9 million ha,
compared to an increase of five million ha for industrial
countries during the same period.
Maize, soya and
cotton remain the three principal GM crops. In the USA biotech
canola, squash, and papaya are also grown. In some countries GM
rice is also produced.
For the first
time a new GM herbicide-tolerant lucerne was commercialised in
the USA. This can be good news for the thousands of lucerne
growers in South Africa.
Biotech soya
continued to be the principal biotech crop, grown on 58.6
million ha, followed by maize 25.2 million ha, cotton 13.4
million ha and canola 4.8 million ha. Herbicide-tolerance has
consistently been the dominant trait followed by insect
resistance and stacked genes.
The main growers
of GM crops continued to be the USA with 54.6 million ha,
followed by Argentina 18 million ha, Brazil 11.5 million ha,
Canada 6.1 million ha, India 3.8 million ha and China 3.5
million ha. South Africa ranks as the eighth largest grower of
biotech crops.
Growth of biotech
crops in the European Union looks promising. Slovakia planted Bt
maize for the first time, bringing the total number of countries
planting biotech crops in the EU to six.
Spain still leads
the way with 60 000 ha Bt maize. Importantly, the collective Bt
maize hectarage in the other five EU countries, France, Czech
Republic, Portugal, Germany and Slovakia increased over
five-fold in 2006, from approximately 1500 ha to 8500 ha. The
biggest increase was in France, from 500 ha in 2005 to 5000 ha
in 2006.
Biotech crop
cultivation is now in its 11th year (eight in South
Africa), despite fearmongering campaigns by activists that GM
crops supposedly pose a health and environmental threat. Not a
shred of medical or scientific evidence has been produced
anywhere in the world to support these claims. To the contrary,
all the world’s leading academies of science and medicine and
agricultural research institutions have given GM food a clean
bill of health.
The future
outlook for GM crops is more promising than ever. Based on the
percentage growth the past ten years, it is anticipated that by
2015 at least 20 million farmers in 40 countries will be growing
biotech crops on 200 million ha. Drought-tolerant crops are
expected to be commercialised by 2010.
By far the most
important potential contribution of biotech crops will be their
contribution to the humanitarian Millennium Development Goals
(MDG) of reducing poverty and hunger by 50% by 2015.
“The policy position of Agri SA regarding biotechnology was
formulated by the group of commodity organisations represented
in the organisation’s Commodity Chamber and can be summarised as
follows: The
organisation is in favour of biotechnology development by means
of genetically modified organisms (GMOs) for the purpose of
attaining sustainable agricultural production and,
simultaneously, promote profitability and competitiveness,
provided that the application thereof does not detrimentally
affect the health of humankind or animals, as well as the
environment,”
Bosman emphasised.
The Chamber has
agreed that specific policy viewpoints of individual commodity
organisations regarding the possible application of
biotechnology as a result of the distinctiveness of the
commodity branches within the three commodity branches of crop
production, horticulture and animal husbandry, be left to these
organisations.
South Africa
has an official national biotechnology strategy, compiled in
2001, and agricultural biotechnology forms an intrinsic part
thereof. It is also government policy that South Africa should
develop its own biotechnological innovations. Agri SA is
satisfied that this strategy complies with the requirements of
the organisation.
It is also the
case with the comprehensive legislation (the GMO Act of 1997,
regulations and procedures) that regulates genetic modification
from research to where it is made available in food form.
Guidelines for biosafety and biosafety requirements have
ensured, since 1990, that safety would be evaluated in depth
before approval will be given for release of a GM crop.
Several new GM
crops are in the pipeline. The first is maize cultivars
resistant to stalk borers and also herbicide-tolerant. Locally
developed maize, groundnuts and soya that will be
drought-tolerant are at present being tested in field
experiments, as well as potatoes with resistance against viruses
and also against the potato tuber moth. Maize with resistance
against maize streak virus has been developed locally. There
have also been breakthroughs regarding wine grapes and sugar
cane.
Research and
technology development represent the corner-stone of sustainable
agricultural development to promote the profitability and
competitiveness of the sector. Agri SA has applied itself in the
immediate past to promote improved agricultural research and
technology development by means of the applicable work structure
– the National Agricultural Research Forum (NARF), of which Agri
SA is a member – and is actively involved in the development of
the proposed Research and Development Strategy of the Department
of Agriculture.
Izak van der
Merwe, chairman of the Research and Technology Committee of Agri
SA, also attended the triennial conference of the Global
Forum on Agricultural Research in New Delhi, India, in
November last year. The conference theme was the reorientation
of agricultural research to reach the Millennium Development
Goals.
Dr John Purchase,
general manager of Grain SA, also attended the Africa Union’s
workshop on the Action Plan of the African Seed and
Biotechnology Program in Addis Ababa, Ethiopia, on 13 and 14
November 2006, on behalf of Agri SA. |